SE9902938D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9902938D0 SE9902938D0 SE9902938A SE9902938A SE9902938D0 SE 9902938 D0 SE9902938 D0 SE 9902938D0 SE 9902938 A SE9902938 A SE 9902938A SE 9902938 A SE9902938 A SE 9902938A SE 9902938 D0 SE9902938 D0 SE 9902938D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- propylsulphonyl
- nedocromil
- phenylethoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902938A SE9902938D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
| AU64603/00A AU6460300A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
| PCT/GB2000/003116 WO2001012192A2 (fr) | 1999-08-18 | 2000-08-14 | Compositions pharmaceutiques |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902938A SE9902938D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9902938D0 true SE9902938D0 (sv) | 1999-08-18 |
Family
ID=20416696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9902938A SE9902938D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6460300A (fr) |
| SE (1) | SE9902938D0 (fr) |
| WO (1) | WO2001012192A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100569760C (zh) | 2003-11-21 | 2009-12-16 | 施万制药 | 具有β2肾上腺素能受体激动剂和毒蕈碱性受体拮抗剂活性的化合物 |
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| UY31905A (es) | 2008-06-18 | 2010-01-29 | Astrazeneca Ab | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902938A patent/SE9902938D0/xx unknown
-
2000
- 2000-08-14 AU AU64603/00A patent/AU6460300A/en not_active Abandoned
- 2000-08-14 WO PCT/GB2000/003116 patent/WO2001012192A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001012192A2 (fr) | 2001-02-22 |
| AU6460300A (en) | 2001-03-13 |
| WO2001012192A3 (fr) | 2001-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20034612L (no) | 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer | |
| WO2002085909A8 (fr) | Derives de 9-deazaguanine utilises comme inhibiteurs de la gsk-3 | |
| ATE504579T1 (de) | Antivirale mittel | |
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| SE9903760D0 (sv) | New compounds | |
| CY2013041I2 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
| CA2396561A1 (fr) | Oxazolidinones substituees et leur utilisation dans le domaine de la coagulation sanguine | |
| GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| WO2004026863A8 (fr) | Nouveaux composes de triazole et d'oxazole, inhibiteurs du facteur de croissance transformant | |
| ITFI20030058A1 (it) | Formulazioni farmaceutiche contenenti tiazolidinedioni | |
| BR0314182A (pt) | Formulações compreendendo um composto de indolinona | |
| SE9902935D0 (sv) | Pharmaceutical compositions | |
| EP1228758A4 (fr) | Agents de prevention ou de traitement de maladies inflammatoires de l'intestin | |
| AU2002358082A1 (en) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
| SE9902937D0 (sv) | Pharmaceutical compositions | |
| SE9902938D0 (sv) | Pharmaceutical compositions | |
| HUP9802897A2 (hu) | Optikailag aktív piridil-4H-1,2,4-oxadiazin-származék, annak alkalmazása vaszkuláris betegségek kezelésére, valamint ilyen származékot hatóanyagként tartalmazó gyógyászati készítmény | |
| SE9902936D0 (sv) | Pharmaceutical compositions | |
| SE0001916D0 (sv) | Novel formulation | |
| BR0011845A (pt) | Complexo farmacêutico | |
| WO2003009835A3 (fr) | Nouvelle utilisation de 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane et de ses sels physiologiquement acceptables | |
| HUP0402654A2 (hu) | 2-[(2'-Halogén-3',5'-dialkoxi-fenil)-imino]-imidazolidin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| BR0213463A (pt) | Composições farmacêuticas contendo macrólidos | |
| FR2843301B1 (fr) | Forme galenique pour la delivrance colique de principes actifs |